4
Changes in Ownership
Immunome Inc. Filed Acc 0001415889-25-020788
Options or other derivatives
- Chief Technical Officer acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tsai Philip Chief Technical Officer | 2025-07-29 | Grant or award · Employee Stock Option (right to buy) | +190,000 | 190,000 | D | ||
Loading xslF345X05/form4-07312025_110740.xml…